Where can researchers source third-party tested DSIP?

Midwest Peptide supplies research-grade DSIP with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

DSIP Neuroprotection Research Studies | Midwest Peptide

Peptides in Research: A Comprehensive Guide to Peptide SciencePrev|DSIP and Stress Response: HPA Axis Research LiteratureNext

DSIP Neuroprotection Research: Published Animal Model Studies

DSIP · Published April 9, 2026 · Updated May 18, 2026 · 8 min read

Quick Answer

DSIP neuroprotection research examines this nonapeptide in rodent models of oxidative stress, ischemia, excitotoxicity, and other neural damage mechanisms. Studies measure neuronal survival, apoptosis markers, and infarct volume across standardized neuroprotection research protocols. For research use only, not for human consumption.

DSIP Neuroprotection Research: Published Animal Model Studies

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

What Is Neuroprotection Research?
DSIP and Oxidative Stress Protection
DSIP and Stress-Mediated Damage
DSIP and Ischemia Research Models
DSIP and Excitotoxicity
DSIP and Inflammation
DSIP and Neurotrophic Factors
Animal Model Considerations
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

DSIP neuroprotection research has emerged as one of the more conceptually interesting areas of preclinical literature on this neuropeptide. Multiple animal model studies have characterized DSIP for effects that may protect neurons from various forms of damage, providing initial evidence on DSIP as a research tool for neuroprotection studies. As the neuroprotection component of the DSIP research cluster, this article reviews the published animal model literature on DSIP neuroprotection effects.

Frequently Asked Questions

What is DSIP in research contexts?

DSIP (Delta Sleep-Inducing Peptide) is a synthetic nonapeptide first identified from cerebral venous blood of rabbits in 1977. It is studied in preclinical models for its effects on sleep architecture, the HPA axis, and neuroprotection.

How is DSIP studied for neuroprotection?

Research uses ischemic stroke models, excitotoxicity (kainate, NMDA challenge), oxidative neural injury, and neurodegeneration paradigms in rodents, examining survival, behavioral recovery, histological damage, and biochemical neuroprotection markers.

What molecular mechanisms underlie DSIP neuroprotection?

Reported mechanisms include antioxidant effects, modulation of glutamate excitotoxicity, anti-inflammatory effects on microglia, and HPA axis buffering that may reduce stress-induced neuronal damage in vulnerable brain regions.

Is DSIP approved for human use?

No. DSIP is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Glossary

Key terms used in this article.

Nonapeptide: A peptide consisting of nine amino acid residues; DSIP has the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu.
Slow-Wave Sleep (SWS): The deepest stage of non-REM sleep, characterized by high-amplitude, low-frequency delta waves on EEG.
HPA Axis: The hypothalamic-pituitary-adrenal axis, a neuroendocrine system regulating the stress response via CRH, ACTH, and glucocorticoids.
ACTH: Adrenocorticotropic hormone, secreted by the anterior pituitary in response to CRH and stimulating glucocorticoid release from the adrenal cortex.
Excitotoxicity: Neuronal injury or death caused by excessive glutamate receptor activation and consequent calcium influx.
Microglia: The resident immune cells of the central nervous system, which mediate neuroinflammation and neuroprotection.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. DSIP is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, and should never be administered to humans or to animals outside of an authorized research protocol.

What Is Neuroprotection Research?

Neuroprotection research focuses on identifying interventions that can protect neurons from various forms of damage including oxidative stress, excitotoxicity, ischemia, inflammation, and various other insults that can damage neural tissue. The goal of neuroprotection research is to characterize molecular mechanisms and research compounds that may be relevant to understanding and addressing neuronal damage in research models.

In animal research models, neuroprotection is typically characterized through measurements of neuronal survival following various insults, functional endpoints that reflect the integrity of neural tissue, biochemical markers of neural damage, and various other approaches. These methods together provide a comprehensive picture of how interventions affect neural protection in research models.

DSIP has been studied in neuroprotection research as one of several neuropeptides characterized for potential neuroprotective effects. The accumulated research provides initial evidence on DSIP as a research tool for neuroprotection studies, although the field is smaller than the literature on some other neuroprotective research compounds.

DSIP and Oxidative Stress Protection

Oxidative stress is one of the major mechanisms of neuronal damage in research models. Neurons are particularly vulnerable to oxidative damage because of their high metabolic demand, their high concentration of polyunsaturated lipids, and their relatively limited regenerative capacity compared to many other cell types.

DSIP has been characterized for effects on oxidative stress endpoints in research models. The published findings include effects on antioxidant gene expression, on antioxidant enzyme activities, and on various other endpoints relevant to cellular antioxidant defense. The integration of these effects with the broader DSIP biology supports the description of the peptide as a potential research tool for studying neuroprotection through antioxidant mechanisms.

The mechanism by which DSIP affects oxidative stress in research models is still being characterized, but the published findings include effects on multiple components of the cellular antioxidant defense system. The combined effects produce the antioxidant profile characterized in research models.

For more on broader antioxidant research with related approaches, see our Glutathione research cluster.

DSIP and Stress-Mediated Damage

The connection between stress biology and neural damage is one of the more important aspects of DSIP neuroprotection research. Chronic or excessive stress responses can produce neural damage in research models through multiple mechanisms including elevated glucocorticoid effects, altered neurotrophic factor expression, and various other pathways. DSIP's effects on stress biology (discussed in our companion article on DSIP HPA axis research) connect to its potential neuroprotective effects through this stress-damage axis.

Research on DSIP and stress-mediated neural damage has examined how the peptide affects neural endpoints in research models exposed to chronic stress or other stress-related challenges. The published findings generally support beneficial effects of DSIP in these contexts, consistent with its modulation of the broader HPA axis and stress response biology.

The integration of DSIP effects on stress biology with effects on neural protection provides one of the more conceptually interesting aspects of the peptide's research profile. The dual effects on both systems make DSIP a useful research tool for studying the integrated biology of stress and neural damage in research models.

DSIP and Ischemia Research Models

Ischemia (reduced blood flow to tissue) is one of the major causes of neural damage in research models, and ischemia-reperfusion research has been one of the contexts for studying DSIP neuroprotection. These research models involve creating defined ischemic injuries in research animals and measuring how interventions affect the resulting tissue damage.

The published findings on DSIP in ischemia research models include effects that may support neural protection in some experimental contexts. The mechanism likely involves multiple components including effects on antioxidant defense, modulation of stress responses, and various other aspects of the integrated DSIP biology.

The research on DSIP in ischemia models is more limited than the research on some other neuroprotective compounds, but it provides initial evidence on DSIP as a research tool for this specific application. Continued research in this area is one of the active topics in the broader DSIP literature.

DSIP and Excitotoxicity

Excitotoxicity refers to neural damage caused by excessive glutamate signaling at NMDA and other glutamate receptors. This form of neural damage is one of the major mechanisms of neuronal death in research models of various neural injury conditions, and interventions that protect against excitotoxicity have been studied extensively in neuroprotection research.

DSIP has been characterized for effects in excitotoxicity research models, with findings that support some level of protection against glutamate-mediated neural damage in research contexts. The mechanism by which DSIP affects excitotoxicity is still being characterized, but the published findings provide initial evidence for effects on this specific damage mechanism.

The integration of excitotoxicity protection with the broader DSIP neuroprotective profile supports the description of DSIP as a potential multi-mechanism neuroprotective research tool. The combined effects on multiple damage mechanisms may produce more comprehensive neural protection than effects on any single mechanism alone.

DSIP and Inflammation

Neural inflammation contributes to neural damage in many research models, and modulation of inflammation is one of the mechanisms by which interventions can produce neuroprotective effects. DSIP has been studied for effects on inflammatory endpoints in some research contexts, providing additional evidence on its potential neuroprotective profile.

The published findings on DSIP and inflammation are more limited than the findings on direct antioxidant effects, but they provide initial evidence on this aspect of DSIP biology. The integration of anti-inflammatory effects with the broader DSIP profile would contribute to the neuroprotective potential of the peptide in research models.

For more on the related anti-inflammatory research with other neuropeptides, see our companion article on VIP neuroinflammation research which discusses a different neuropeptide with documented anti-inflammatory effects in research models.

DSIP and Neurotrophic Factors

Neurotrophic factors including BDNF and NGF are important regulators of neural survival and function. Research on DSIP and neurotrophic factors has examined whether the peptide affects neurotrophic factor expression or function in research models, with findings that may contribute to the broader neuroprotective profile.

The connection to neurotrophic factor research links DSIP to the broader literature on peptides that affect BDNF and NGF expression in research models. For comparative context, see our Selank BDNF research article and Semax BDNF NGF research article which discuss other neuropeptides with documented neurotrophic effects.

The integration of neurotrophic factor effects with the broader DSIP biology would contribute to the neuroprotective profile, although the specific evidence on DSIP and neurotrophic factors is more limited than the evidence on its sleep and HPA axis effects.

Animal Model Considerations

Animal model studies of DSIP neuroprotection have used various research approaches to characterize the peptide's effects. These include cell culture models of neural damage, animal models of specific neural injuries, and various other approaches that probe different aspects of neural biology.

The published research provides initial evidence on DSIP neuroprotection in research models, but the field is smaller than the literature on some other neuroprotective compounds. Continued research on DSIP in standardized neural protection models is one of the active areas of the broader DSIP literature.

The cross-species and cross-model convergence of findings provides the strongest evidence for DSIP neuroprotective effects. The accumulated research base supports the use of DSIP as a research tool for studies of neural protection in various research contexts.

Open Research Questions

Several open research questions remain in the DSIP neuroprotection literature. These include the precise molecular mechanism by which DSIP affects neural cell survival, how DSIP neuroprotection effects integrate with its broader sleep and stress biology, and how DSIP compares with other neuroprotective research compounds in standardized research models. Each of these is a legitimate research opportunity for investigators studying neuroprotection biology.

Conclusion

DSIP neuroprotection research has emerged as one of the more conceptually interesting areas of preclinical literature on this neuropeptide. The published findings on antioxidant effects, stress-mediated damage protection, ischemia research, excitotoxicity, and other neural damage mechanisms provide initial evidence on DSIP as a research tool for neuroprotection studies. For investigators using DSIP as a research tool, the neuroprotection literature provides essential context for experimental design.

For more on the full DSIP research cluster, see the pillar overview article and the supporting articles on each major topic.

DSIP is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

DSIP, 99%+ purity, COA included
Glutathione 1500mg, 99%+ purity, COA included
VIP 10mg, 99%+ purity, COA included
Selank 10mg, 99%+ purity, COA included
Semax 10mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

DSIP Neuroprotection Research: Published Animal Model Studies